Upgrade to SI Premium - Free Trial

Applied DNA to Exhibit Security Print Platform Developed With Videojet Technologies at Defense Manufacturing Conference 2017 in Tampa on December 4-6

November 28, 2017 5:30 AM

Co-Branded Applied DNA SigNature® Molecular-Tagged Videojet Inks and Co-Branded Printer on Display at Booth #1019

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN) will exhibit its new security print platform developed with Videojet Technologies (Videojet) at the Defense Manufacturing Conference 2017 (DMC 2017) in Tampa, FL on December 4-6 at Booth #1019. Janice Meraglia, Vice President of Government & Military Programs, and Bob MacDowell, Director of Government & Military Programs, will be attending the conference.

The platform utilizes Videojet’s recently released 1860 continuous inkjet printer, which is co-branded with Applied DNA, along with co-branded Videojet inks that incorporate Applied DNA’s unique SigNature® molecular tag into each individual Smart CartridgeTM ink cartridge. The SigNature molecular ink is a turnkey, high-volume ink that offers per-part traceability. The inks are brand-specific, enabling each brand to tag, test and track their products from source to shelf under a CertainT® licensing agreement.

The initial rollout of co-branded SigNature molecular-tagged inks includes an aerospace-approved ink. This durable black ink was chosen to qualify first, due to its specific application and use in the U.S. military and aerospace industry for item unique identifier (IUID) tags for an array of critical components spanning several Federal Supply Groups (FSGs).

Janice Meraglia said, “We look forward to showcasing this unique platform, which is designed to enable defense suppliers to forensically tag products and packaging. Once tagged, other supply chain participants can independently conduct in-field tests along the supply chain, track globally to certify product claims, and prevent diversion and counterfeits.”

The DMC is where top government and industry leaders and manufacturing subject matter experts gather to communicate and collaborate on policies, strategic direction, best practices, funding opportunities, and the latest innovations in support of defense manufacturing priorities. The DMC will be conducted simultaneously with the Diminishing Manufacturing Sources and Material Shortages (DMSMS) Conference.

If you are interested in meeting with Applied DNA at the conference, please contact Janice Meraglia directly at [email protected].

About Videojet Technologies

Videojet Technologies is a world-leader in the product identification market, providing in-line printing, coding, and marking products, application specific fluids, and product life cycle services. Our goal is to partner with our customers in the consumer packaged goods, pharmaceutical, and industrial goods industries to improve their productivity, to help protect and grow their brands, and to stay ahead of industry trends and regulations. With our customer application experts and technology leadership in continuous inkjet (CIJ), thermal inkjet (TIJ), laser marking, thermal transfer overprinting (TTO), case coding and labeling, and wide array printing, Videojet has more than 345,000 printers installed worldwide. Our customers rely on Videojet products to print on over ten billion products daily. Customer sales, application, service, and training support is provided by direct operations with over 4,000 team members in 26 countries worldwide. In addition, the Videojet distribution network includes more than 400 distributors and OEMs, serving 135 countries.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements

The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investors:

LHA Investor Relations

Sanjay M. Hurry, 212-838-3777

[email protected]

or

Media:

Dian Griesel Int’l

Cheryl Schneider, 212-825-3210

[email protected]

or

Program:

Janice Meraglia, 631-240-8821

[email protected]

web: www.adnas.com | twitter: @APDN

Source: Applied DNA Sciences, Inc.

Categories

Press Releases